© 2024 Kansas City Public Radio
NPR in Kansas City
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

ABC's Robin Roberts Vows To Beat Blood Disorder

<em>Good Morning America</em>'s Robin Roberts on the show today.
Good Morning America
Good Morning America's Robin Roberts on the show today.

Good Morning America co-anchor Robin Roberts told the ABC-TV show's viewers today that she's been diagnosed with myelodysplastic syndrome (MDS), "a disease of the blood and bone marrow and was once known as preleukemia."

She also said "doctors tell me I'm going to beat this — and I know it's true."

Roberts, who five years ago "beat breast cancer," as she put it, added that "sometimes the treatment for cancer can cause other serious medical problems." In her case, chemotherapy apparently led to the MDS. Here's how The Washington Post's The Checkup blog describes MDS:

"A rare blood disorder in which 'the bone marrow produces enough blood cells, but they're fragile, or cracked, so when they try to get into the blood stream to do what they do, they break apart prematurely,' explains Martin Tallman, chief of the leukemia service at Memorial Sloan-Kettering Cancer Center in New York."

Roberts, 51, said that among the reasons her prognosis is good is that while "bone marrow donors are scarce and particularly for African-American women, I am very fortunate to have a sister who is an excellent match, and this greatly improves my chances for a cure."

Tallman tells Checkup that doctors have "shifted away" from calling the procedures "bone marrow transplants," in favor of "stem cell transplants."

Roberts expects to be able to keep doing her job, though she may "miss a day here or there."

Copyright 2020 NPR. To see more, visit https://www.npr.org.

Mark Memmott is NPR's supervising senior editor for Standards & Practices. In that role, he's a resource for NPR's journalists – helping them raise the right questions as they do their work and uphold the organization's standards.
KCUR prides ourselves on bringing local journalism to the public without a paywall — ever.

Our reporting will always be free for you to read. But it's not free to produce.

As a nonprofit, we rely on your donations to keep operating and trying new things. If you value our work, consider becoming a member.